New Drug Telavancin Tops Vancomycin in Patients with MRSA Skin Infections: Presented at ICAAC
A new drug in a similar class as vancomycin — a last resort antibiotic — appears to clear up dangerous methicillin-resistant Staphylococcus aureus (MRSA) skin infections more effectively than standard treatment.
“Usually that standard of care is vancomycin,” said Martin Stryjewski, MD, Attending Physician, Internal Medicine and Infectious Diseases, Cemic Hospital, Buenos Aires, Argentina.
.gif)
1 response so far ↓
samur ralies // Nov 20, 2008 at 10:50 am
Cubist’s drug Cubicin (Daptomycin) is less toxic and when coadministered with a cef drug it has better cidal activity against MRSA. I don’t know why vanco is the last resort drug to the media.
Leave a Comment